Bibliography
- Davignon J. Prospects for drug therapy for hyperliproteineamia. Diabetes Metab 1995;21:139-46
- Engler H, Riesen WF. Effect of thyroid function on concentrations of lipoprotein (a). Clin Chem 1993;39:2466-9
- de Bruin TW. Lipiporotein(a) and apolipoprotein B plasma concentrations in hypothyroid, euthryoid and hyperthyroid subjects. J Clin Endocrinol Metab 1993;76:121-6
- Baxter JD, Scanlane T. Selective modulation of thyroid hormone receptor action. J Steroid Biochem Mol Bio 2001;76:31-42
- Webb P. Selective activators of thyroid hormone receptors. Expert Opin Investig Drugs 2004;13:489-500
- Cutting WC. Relationship between blood cholesterol and increased metabolism from dinitrophenol and thyroid. J Clin Invest 1934;13:547-52
- Baxter JD, Kristensen J. The thyroid hormone mimetic compound KB2115 lowers plasma LDL cholesterol and stimulates bile acid synthesis without cardiac effects in humans. Proc Natl Acad Sci USA 2008;105:663-7
- Erion M. Targeting thyroid hormone receptor-beta agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index. Proc Natl Acad Sci USA 2007;104:15491
- Quatrx Pharmaceuticals Co. WO2009089093; 2009
- St Germain DL. The deiodinase family of selenoproteins. Thyroid 1997;7:655-68
- Christian EW. Current approaches for the treatment with thyroid hormone analogs. Recent Patents Endocr Metabol Immune Drug Discov 2008;2:1-8
- Scanlan T. Selective thyromimetics: tissue-selective thyroid hormone analogs. Curr Opin Drug Discov Dev 2001;4:614-22
- Gregory D. Identification of simple substituted phenols with thyromimetic activity: cardiac effects of 3, 5-diiodo-4-hydroxyphenylpropionic acid. J Pharmacol Exp Ther 1992;263:163-9
- Morkin E. Thyroid hormone analogs for treatment of hypercholesterolemia and heart failure: past, present and future prospects. J Mol Cell Cardiol 2004;37:1137-46
- Dillmann WH. Thyroid hormone action and cardiac contractility a Complex affair. Endocrinology 1996;37:799-801
- Klein I, Ojamaa K. Thyrotoxicosis and the heart. Endocrinol Metab Clin North Am 1998;27:51-62
- Dillmann WH. Biochemical basis of thyroid hormone action in the heart. Am J Med 1990;88:626-30
- Balkman C, Ojamaa K, Klein I. Time course of the in vivo effects of thyroid hormone on cardiac gene expression. Endocrinology 1992;130:2001-6
- Kaneshige M, Cheng S. Mice with a targeted mutation in the thyroid hormone beta receptor gene exhibit impaired growth and resistance to thyroid hormone. Proc Natl Acad Sci USA 2000;97:13209-14
- Swynghedauw B. Developmental and functional adaptation of contractile proteins in cardiac and skeletal muscles. Physiol Rev 1986;66:710-71
- Stasilli NR. Antigoitrogenic and calorigenic activities of thyroxine analogues in rats. Endocrinology 1959;64:62-82
- Pennock GD. Cardiac effects of 3,5-diiodothyropropionic acid: a thyroid hormone analog with inotropic selectivity. J Pharmacol Exp Ther 1992;263:163-9
- Steven G. DITPA (3,5-Diiodothyropropionic Acid), a thyroid hormone analog to treat heart failure. Circulation 2009;119:3093-100
- Baxter JD, Grover GJ. Anti-obesity, anti-diabetic, and lipid lowering effects of the thyroid receptor beta subtype selective agonist KB-141. J Steroid Biochem Mol Bio 2008;111:262-7